SGRY Earnings & Financial Statements
Surgery Partners, Inc.
$14.83
+$0.28(+1.92%)
45
Overall
60
Value
20
Tech
55
Quality
Market Cap
$1.94B
Volume
1.44M
52W Range
$11.41 - $23.44
Target Price
$18.82
SGRY earnings and financial statements: Surgery Partners, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SGRY Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.31B | $3.11B | $2.74B | $2.54B | $2.23B |
| Cost of revenue | $2.54B | $2.37B | $2.10B | $1.96B | $1.73B |
| Operating income | $389.50M | $348.80M | $328.00M | $345.20M | $302.20M |
| EBITDA | $565.50M | $501.40M | $446.10M | $460.00M | $401.00M |
| Net income | -$77.90M | -$168.10M | -$11.90M | -$54.60M | -$70.90M |
| EPS (diluted) | $-0.61 | $-1.33 | $-0.09 | $-0.59 | $-1.12 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $8.12B | $7.89B | $6.88B | $6.68B | $6.12B |
| Total liabilities | $4.59B | $4.25B | $3.51B | $3.40B | $3.82B |
| Shareholders’ equity | $1.71B | $1.79B | $1.99B | $2.00B | $1.09B |
| Cash and equivalents | $239.90M | $269.50M | $195.90M | $282.90M | $389.90M |
| Long-term debt | $3.88B | $3.56B | $2.95B | $2.83B | $3.19B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $274.30M | $300.10M | $293.80M | $158.80M | $87.10M |
| Capital expenditure | -$32.20M | -$87.80M | -$88.80M | -$80.60M | -$57.60M |
| Free cash flow | $195.60M | $209.70M | $205.00M | $78.20M | $29.50M |
| Dividends paid | $226.00M | $170.50M | $146.10M | - | $136.10M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SGRY | $14.83 | +1.9% | 1.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |